Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

FDA Okays A.I.-Guided Wrist Fracture Software

Bones in the wrist and hand

The U.S. Food and Drug Administration authorized marketing of software to help diagnose wrist fractures using machine-learning algorithms to read and interpret X-ray images. . . . → Read More: FDA Okays A.I.-Guided Wrist Fracture Software

FDA Urges More Industry Sun Protection Research

Sun exposure

The head of the U.S. Food and Drug Administration is asking companies making sunscreen to conduct more research on the safety of products that protect against harmful sun rays. . . . → Read More: FDA Urges More Industry Sun Protection Research

Cannabis Derivative Shown to Reduce Severe Seizures

Epilepsy graphic

A clinical trial shows treatments made with cannabidiol, a medical-grade derivative of cannabis plants, reduce the number of severe seizures in people with Lennox–Gastaut syndrome, when combined with conventional drugs. . . . → Read More: Cannabis Derivative Shown to Reduce Severe Seizures

Clinical Trials Okayed for Sickle Cell Gene Editing

Sickle cell illustration

Two companies developing therapies for inherited blood disorders say the Food and Drug Administration approved their application to begin clinical trials of treatments for sickle cell disease with gene editing. . . . → Read More: Clinical Trials Okayed for Sickle Cell Gene Editing

FDA Clears A.I. Software Detecting Diabetic Eye Disease

Fundus photograph

The Food and Drug Administration authorized a system for detecting diabetic retinopathy, a condition threatening the vision of people with diabetes, that uses artificial intelligence to analyze images of patients’ retinas. . . . → Read More: FDA Clears A.I. Software Detecting Diabetic Eye Disease

Gene Therapy Biotech Acquired in $8.7 Billion Deal

A biotechnology enterprise developing gene therapies for rare inherited diseases and neurological disorders is being acquired by pharmaceutical company Novartis AG for $8.7 billion. . . . → Read More: Gene Therapy Biotech Acquired in $8.7 Billion Deal

FDA Authorizes Interoperable Glucose Monitoring System

The Food and Drug Administration authorized a device that electronically monitors blood glucose levels in people with diabetes, but is also designed to exchange data with other compatible electronic systems. . . . → Read More: FDA Authorizes Interoperable Glucose Monitoring System

High False-Positive Rate Found in Consumer Genetic Tests

Follow-up reviews of results from direct-to-consumer genetic tests show 40 percent of the actionable gene variations reported in the tests, including some indicating disease risk, were erroneous. . . . → Read More: High False-Positive Rate Found in Consumer Genetic Tests

Trials Show Pain Drug Reduces Post-Surgery Opioid Use

Initial results from two late-stage clinical trials show an experimental pain drug with non-opioid ingredients reduces the use of opioid pain relievers following surgery, compared to a placebo and standard care. . . . → Read More: Trials Show Pain Drug Reduces Post-Surgery Opioid Use

Quick Bacterial Blood Detection Gains Breakthrough Tag

A technology that detects dangerous bacteria in patients’ blood samples in less than an hour received a breakthrough medical device designation from the U.S. Food and Drug Administration. . . . → Read More: Quick Bacterial Blood Detection Gains Breakthrough Tag